(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1346203 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PTPRE mRNA CTD PMID:22079256 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of PTPRE mRNA CTD PMID:26682919 1,2-dimethylhydrazine affects expression EXP 6480464 1, 2-Dimethylhydrazine affects the expression of PTPRE mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of PTPRE mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PTPRE mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1346203 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PTPRE mRNA, [Estradiol co-treated with TGFB1 protein] results in increased expression of PTPRE mRNA CTD PMID:19619570 , PMID:30165855 17beta-estradiol multiple interactions ISO RGD:620771 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PTPRE mRNA CTD PMID:32741896 17beta-estradiol increases expression ISO RGD:1346203 6480464 Estradiol results in increased expression of PTPRE mRNA CTD PMID:19619570 , PMID:31614463 17beta-estradiol 3-benzoate multiple interactions ISO RGD:620771 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PTPRE mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1346203 6480464 Tetrachlorodibenzodioxin results in increased expression of PTPRE mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:620771 6480464 Tetrachlorodibenzodioxin results in increased expression of PTPRE mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PTPRE mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PTPRE mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1346203 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of PTPRE mRNA, [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PTPRE mRNA CTD PMID:19619570 , PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1346203 6480464 Tetrachlorodibenzodioxin results in decreased expression of PTPRE mRNA CTD PMID:19619570 2-hydroxypropanoic acid decreases expression ISO RGD:1346203 6480464 Lactic Acid results in decreased expression of PTPRE mRNA CTD PMID:30851411 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PTPRE mRNA CTD PMID:30951980 8-Br-cAMP increases expression ISO RGD:1346203 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PTPRE mRNA CTD PMID:22079614 acetamide increases expression ISO RGD:620771 6480464 acetamide results in increased expression of PTPRE mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO RGD:1346203 6480464 Aflatoxin B1 results in increased expression of PTPRE mRNA CTD PMID:21641981 aflatoxin B1 affects methylation ISO RGD:1346203 6480464 Aflatoxin B1 affects the methylation of PTPRE intron CTD PMID:30157460 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of PTPRE mRNA CTD PMID:16604517 all-trans-retinoic acid increases expression ISO RGD:1346203 6480464 Tretinoin results in increased expression of PTPRE mRNA CTD PMID:21934132 more ... ammonium chloride affects expression ISO RGD:620771 6480464 Ammonium Chloride affects the expression of PTPRE mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1346203 6480464 Antirheumatic Agents results in decreased expression of PTPRE mRNA CTD PMID:24449571 arsane multiple interactions ISO RGD:1346203 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of PTPRE mRNA CTD PMID:32525701 arsane affects methylation ISO RGD:1346203 6480464 Arsenic affects the methylation of PTPRE gene CTD PMID:25304211 arsane affects expression ISO RGD:1346203 6480464 Arsenic affects the expression of PTPRE mRNA CTD PMID:25304211 arsenic atom multiple interactions ISO RGD:1346203 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of PTPRE mRNA CTD PMID:32525701 arsenic atom affects methylation ISO RGD:1346203 6480464 Arsenic affects the methylation of PTPRE gene CTD PMID:25304211 arsenic atom affects expression ISO RGD:1346203 6480464 Arsenic affects the expression of PTPRE mRNA CTD PMID:25304211 arsenite(3-) decreases expression EXP 6480464 arsenite results in decreased expression of PTPRE mRNA CTD PMID:18191166 arsenous acid increases expression ISO RGD:1346203 6480464 Arsenic Trioxide results in increased expression of PTPRE mRNA CTD PMID:22521957 benzene increases expression ISO RGD:1346203 6480464 Benzene results in increased expression of PTPRE mRNA CTD PMID:15929907 benzo[a]pyrene increases expression ISO RGD:1346203 6480464 Benzo(a)pyrene results in increased expression of PTPRE mRNA CTD PMID:20106945 , PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1346203 6480464 Benzo(a)pyrene affects the methylation of PTPRE 5' UTR, Benzo(a)pyrene affects the methylation of PTPRE intron CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of PTPRE mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of PTPRE mRNA CTD PMID:19770486 , PMID:21569818 benzo[e]pyrene decreases methylation ISO RGD:1346203 6480464 benzo(e)pyrene results in decreased methylation of PTPRE promoter CTD PMID:30157460 bisphenol A affects expression ISO RGD:620771 6480464 bisphenol A affects the expression of PTPRE mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:1346203 6480464 bisphenol A results in increased methylation of PTPRE gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1346203 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PTPRE gene CTD PMID:31601247 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PTPRE promoter CTD PMID:27312807 butan-1-ol multiple interactions ISO RGD:1346203 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PTPRE mRNA CTD PMID:29432896 calcitriol increases expression ISO RGD:1346203 6480464 Calcitriol results in increased expression of PTPRE mRNA CTD PMID:16002434 CGP 52608 multiple interactions ISO RGD:1346203 6480464 CGP 52608 promotes the reaction [RORA protein binds to PTPRE gene] CTD PMID:28238834 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of PTPRE mRNA CTD PMID:23125180 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of PTPRE mRNA CTD PMID:32715474 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of PTPRE more ... CTD PMID:20938992 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of PTPRE mRNA CTD PMID:28472532 chromium(6+) decreases expression ISO RGD:1346203 6480464 chromium hexavalent ion results in decreased expression of PTPRE mRNA CTD PMID:30690063 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of PTPRE mRNA CTD PMID:21151649 cisplatin increases expression ISO RGD:1346203 6480464 Cisplatin results in increased expression of PTPRE mRNA CTD PMID:27392435 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of PTPRE mRNA CTD PMID:17585979 Cuprizon decreases expression ISO RGD:620771 6480464 Cuprizone results in decreased expression of PTPRE mRNA CTD PMID:26577399 cyclosporin A increases methylation ISO RGD:1346203 6480464 Cyclosporine results in increased methylation of PTPRE promoter CTD PMID:27989131 diarsenic trioxide increases expression ISO RGD:1346203 6480464 Arsenic Trioxide results in increased expression of PTPRE mRNA CTD PMID:22521957 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of PTPRE mRNA CTD PMID:21266533 dibutyl phthalate decreases expression ISO RGD:620771 6480464 Dibutyl Phthalate results in decreased expression of PTPRE mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO RGD:1346203 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan multiple interactions ISO RGD:1346203 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of PTPRE mRNA CTD PMID:26159488 endosulfan increases expression ISO RGD:620771 6480464 Endosulfan results in increased expression of PTPRE mRNA CTD PMID:29391264 ethyl methanesulfonate increases expression ISO RGD:1346203 6480464 Ethyl Methanesulfonate results in increased expression of PTPRE mRNA CTD PMID:23649840 fenthion decreases expression EXP 6480464 Fenthion results in decreased expression of PTPRE mRNA CTD PMID:34813904 fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of PTPRE mRNA CTD PMID:28329830 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of PTPRE more ... CTD PMID:20938992 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of PTPRE mRNA CTD PMID:25629700 formaldehyde decreases expression ISO RGD:1346203 6480464 Formaldehyde results in decreased expression of PTPRE mRNA CTD PMID:20655997 formaldehyde increases expression ISO RGD:1346203 6480464 Formaldehyde results in increased expression of PTPRE mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:1346203 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PTPRE gene CTD PMID:31601247 gentamycin increases expression ISO RGD:620771 6480464 Gentamicins results in increased expression of PTPRE mRNA CTD PMID:22061828 , PMID:33387578 hydrazine decreases expression EXP 6480464 hydrazine results in decreased expression of PTPRE mRNA CTD PMID:15282401 inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PTPRE mRNA CTD PMID:36331819 isobutanol multiple interactions ISO RGD:1346203 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PTPRE mRNA CTD PMID:29432896 ivermectin decreases expression ISO RGD:1346203 6480464 Ivermectin results in decreased expression of PTPRE protein CTD PMID:32959892 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of PTPRE more ... CTD PMID:20938992 methapyrilene decreases methylation ISO RGD:1346203 6480464 Methapyrilene results in decreased methylation of PTPRE promoter CTD PMID:30157460 methidathion decreases expression EXP 6480464 methidathion results in decreased expression of PTPRE mRNA CTD PMID:34813904 methylmercury chloride increases expression ISO RGD:1346203 6480464 methylmercuric chloride results in increased expression of PTPRE mRNA CTD PMID:28001369 mitoxantrone affects response to substance ISO RGD:1346203 6480464 PTPRE protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 N-methyl-4-phenylpyridinium decreases expression ISO RGD:620771 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of PTPRE mRNA CTD PMID:28801915 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of PTPRE mRNA CTD PMID:24535843 nickel atom increases expression ISO RGD:1346203 6480464 Nickel results in increased expression of PTPRE mRNA CTD PMID:24768652 , PMID:25583101 oxaliplatin multiple interactions ISO RGD:620771 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PTPRE mRNA CTD PMID:25729387 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of PTPRE mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:620771 6480464 Acetaminophen results in increased expression of PTPRE mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PTPRE mRNA CTD PMID:36331819 phenethyl isothiocyanate increases expression ISO RGD:620771 6480464 phenethyl isothiocyanate results in increased expression of PTPRE mRNA CTD PMID:17616710 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of PTPRE mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1346203 6480464 Phenylmercuric Acetate results in increased expression of PTPRE mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1346203 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PTPRE mRNA CTD PMID:27188386 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of PTPRE mRNA CTD PMID:20813756 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PTPRE mRNA CTD PMID:19710929 potassium chromate multiple interactions ISO RGD:1346203 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PTPRE mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1346203 6480464 potassium chromate(VI) results in decreased expression of PTPRE mRNA CTD PMID:22079256 , PMID:22714537 rac-lactic acid decreases expression ISO RGD:1346203 6480464 Lactic Acid results in decreased expression of PTPRE mRNA CTD PMID:30851411 raloxifene multiple interactions ISO RGD:1346203 6480464 [Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of PTPRE mRNA CTD PMID:19059307 raloxifene affects expression ISO RGD:1346203 6480464 Raloxifene Hydrochloride affects the expression of PTPRE mRNA CTD PMID:14699072 resveratrol increases expression ISO RGD:1346203 6480464 resveratrol results in increased expression of PTPRE mRNA, resveratrol results in increased expression of PTPRE protein CTD PMID:26911335 resveratrol multiple interactions ISO RGD:1346203 6480464 PTPRE protein affects the reaction [resveratrol results in decreased phosphorylation of STAT3 protein] CTD PMID:26911335 SB 431542 multiple interactions ISO RGD:1346203 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom increases expression EXP 6480464 Silver results in increased expression of PTPRE mRNA CTD PMID:27131904 silver(0) increases expression EXP 6480464 Silver results in increased expression of PTPRE mRNA CTD PMID:27131904 sodium arsenate multiple interactions ISO RGD:1346203 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of PTPRE mRNA CTD PMID:32525701 sodium arsenite affects methylation ISO RGD:1346203 6480464 sodium arsenite affects the methylation of PTPRE gene CTD PMID:28589171 sunitinib decreases expression ISO RGD:1346203 6480464 Sunitinib results in decreased expression of PTPRE mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1346203 6480464 Tamoxifen affects the expression of PTPRE mRNA CTD PMID:14699072 tamoxifen multiple interactions ISO RGD:1346203 6480464 [Tamoxifen co-treated with ESR1 protein] results in increased expression of PTPRE mRNA CTD PMID:19059307 temozolomide decreases expression ISO RGD:1346203 6480464 Temozolomide results in decreased expression of PTPRE mRNA CTD PMID:31758290 testosterone multiple interactions ISO RGD:620771 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PTPRE mRNA CTD PMID:32741896 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of PTPRE mRNA CTD PMID:27339419 theophylline increases expression ISO RGD:1346203 6480464 Theophylline results in increased expression of PTPRE mRNA CTD PMID:18951874 thioacetamide increases expression ISO RGD:620771 6480464 Thioacetamide results in increased expression of PTPRE mRNA CTD PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of PTPRE mRNA CTD PMID:23557971 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of PTPRE mRNA CTD PMID:29264374 topotecan multiple interactions ISO RGD:620771 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of PTPRE mRNA CTD PMID:25729387 topotecan decreases expression ISO RGD:620771 6480464 Topotecan results in decreased expression of PTPRE mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:620771 6480464 Trichloroethylene results in increased expression of PTPRE mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1346203 6480464 trichostatin A results in increased expression of PTPRE mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1346203 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PTPRE mRNA CTD PMID:27188386 triptonide increases expression EXP 6480464 triptonide results in increased expression of PTPRE mRNA CTD PMID:33045310 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of PTPRE mRNA CTD PMID:28973697 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of PTPRE mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:1346203 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PTPRE mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1346203 6480464 Valproic Acid results in increased expression of PTPRE mRNA CTD PMID:23179753 more ... vanadyl sulfate increases expression ISO RGD:1346203 6480464 vanadyl sulfate results in increased expression of PTPRE mRNA CTD PMID:16330358